Instrumento Inactivo

Publs. oficiales CROSSJECT Euronext Paris

Acciones

Precio de cierre Euronext Paris Otros sitios de cotización
- ^EUR	-

10/07	Crossject obtiene una financiación pública de 7 millones de euros para su nuevo producto de epinefrina	MT
10/07	Bolsa de Madrid: Mercados conectados a la corriente alterna

Monthly statement on voting rights	30/09/23	CO
1st-half-year results	26/09/23	CO
1st-half-year results	26/09/23	CO
Monthly statement on voting rights	31/08/23	CO
Monthly statement on voting rights	31/07/23	CO
Monthly statement on voting rights	30/06/23	CO
Minutes of the general assembly	07/06/23	CO
Changes in management and corporate officers	01/06/23	CO
Changes in management and corporate officers	01/06/23	CO
Monthly statement on voting rights	31/05/23	CO
Mixed general shareholder meeting	22/05/23	CO
Mixed general shareholder meeting	03/05/23	CO
Monthly statement on voting rights	30/04/23	CO
Annual Report	28/04/23	CO
Monthly statement on voting rights	31/03/23	CO
Annual results	20/03/23	CO
Annual results	20/03/23	CO
Provisional calendar	01/02/23	CO
Monthly statement on voting rights	31/01/23	CO
Monthly statement on voting rights	31/12/22	CO
Monthly statement on voting rights	30/11/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	30/11/22	CO
Monthly statement on voting rights	31/10/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	29/10/22	CO
Admission of new securities	26/10/22	CO